Last reviewed · How we verify
GRAd-COV2
At a glance
| Generic name | GRAd-COV2 |
|---|---|
| Sponsor | ReiThera Srl |
| Modality | Biologic |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Study of GRAd-COV2 for the Prevention of COVID-19 in Adults (PHASE2, PHASE3)
- Phase I Study to Assess the Safety and Immunology of a COVID-19 Vaccine With GRAd-COV2 Vaccine (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |